CHD Q3 Earnings Beat, Robust Consumer Demand Drives Sales Growth

In This Article:

Church & Dwight Co., Inc. CHD reported impressive third-quarter 2024 results, with the top and bottom lines increasing year over year. Quarterly earnings and net sales surpassed the Zacks Consensus Estimate. The results were driven by strong consumer demand across CHD's portfolio, the resilience of its brands, successful new product launches and continued commitment to effective execution.

Quarterly adjusted earnings of 79 cents per share beat the Zacks Consensus Estimate of 68 cents. The bottom line increased 6.8% year over year, buoyed by better-than-expected sales growth and gross margin expansion.

Find the latest EPS estimates and surprises on Zacks Earnings Calendar.

Net sales of $1,510.6 million advanced 3.8% year over year and surpassed the Zacks Consensus Estimate of $1,493.8 million. The upside can be attributed to robust consumer demand across its portfolio. Organic sales increased 4.3% due to gains from volume to the tune of 3.1% and the favorable product mix and pricing of 1.2%. We had expected organic sales growth of 2.9% in the quarter. The global online sales accounted for 20.7% of total consumer sales in the third quarter.

Church & Dwight Co., Inc. Price, Consensus and EPS Surprise

Church & Dwight Co., Inc. Price, Consensus and EPS Surprise
Church & Dwight Co., Inc. Price, Consensus and EPS Surprise

Church & Dwight Co., Inc. price-consensus-eps-surprise-chart | Church & Dwight Co., Inc. Quote

A Closer Look at CHD’s Q3 Results

Church & Dwight’s gross margin expanded 80 basis points (bps) to 45.2%. The adjusted gross margin was 45%, up 60 bps on the back of enhanced productivity as well as gains from favorable volumes and mix.

Marketing expenses increased $18 million year over year to $185.8 million. As a percentage of net sales, the figure increased by 80 bps to 12.3% on persistent investment in brands and new products.

The adjusted SG&A expenses, as a percentage of net sales, increased 20 bps to 15%, due to investments in international operations, research and development, as well as Information technology.

CHD Provides Q3 Insights by Segment

Consumer Domestic: Net sales in the segment increased 3.3% to $1,170.8 million on the back of improved personal care sales growth. Our estimate for segment sales for the quarter was $1,155.8 million. Organic sales increased 3.3%, driven by favorable price and product mix (up 0.7%) and volume (up 2.6%). The uptick was backed by strength in THERABREATH mouthwash, HERO acne products, ZICAM supplements, ARM & HAMMER Scent Boosters and SPINBRUSH toothbrushes. These gains were somewhat offset by softness in the vitamin business and FLAWLESS.

Consumer International: Net sales in the segment increased 9.5% to $267.7 million. Our estimate for segment sales was $264.7 million. Organic sales jumped 8.1%, driven by favorable pricing and a product mix of 2.8% and higher volumes to the tune of 5.3%. Sales growth was fueled by THERABREATH, HERO and OXICLEAN.

Specialty Products: Sales in the segment declined 8% to $72.1 million, including the impact of winding down the Megalac business. Our estimate for segment sales was $71.9 million. Organic sales grew by 7.5%, driven by higher prices and an improved product mix, which contributed 3.9% along with a volume increase of 3.6%.